The imaging software can automatically differentiate between a calcified and non-calcified blockage, detect the severity of calcium-based blockages and measure vessel diameter
Abbott has announced that it has launched its new vascular imaging platform powered by Ultreon 1.0 Software in India. This software combines optical coherence tomography (OCT) with the power of artificial intelligence (AI) providing physicians a comprehensive view of blood flow and blockages within coronary arteries. The imaging software can automatically differentiate between a calcified and non-calcified blockage, detect the severity of calcium-based blockages and measure vessel diameter. In addition, it helps physicians guide precise stent deployment, ensure optimal stent expansion and apposition with instantaneous display of results to enhance precision during coronary stenting procedures.
Abbott’s OCT technology uses near-infrared light to provide high-definition, precise imaging from within a blood vessel, allowing physicians to capture information from even the most complex patient anatomy. The software enables a streamlined workflow that facilitates accurate and faster decision-making, reduces ambiguities to focus on what’s most important: caring for the patient and improving their quality of life.
With the launch of Ultreon 1.0 Software, Abbott is further leveraging OCT technology to help physicians make better treatment decisions for their patients.
Tushar Sharma, General Manager for Abbott’s vascular business in India and South Asia said, “Increased adoption of OCT imaging, when combined with advanced technology like AI, allows cardiologists to have a more precise and measurable way of supporting patients undergoing coronary stent procedures. Ultreon 1.0 Software can potentially improve physician and patient experience by increasing accuracy of diagnosis and application of therapies. It takes the guesswork out of stent placement.”